Regenxbio RGNX 深 沪
已收盘 08-14 16:00:00 美东时间
10.765
+0.105
+0.98%
华盛通- 最 高10.86
- 今 开10.68
- 成交量 79.25万股
- 最 低 10.34
- 昨 收 10.66
- 总市值 7.11亿
- 52周最高 16.19
- 市盈率 静 --
- 换手率 1.20%
- 52周最低 5.455
- 委 比 -45.39%
- 总股本 6601.32万
- 历史最高 85.10
- 量 比 0.80
- 振 幅 4.88%
- 历史最低 5.035
- 每 手 1
- 风险率 2.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
This HubSpot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Canaccord Genuity analyst David Hynes downgraded Commerce.Com Inc (NASDAQ:CMRC) from Buy to Hold ...
08-07 19:54
Barclays Downgrades Regenxbio to Equal-Weight, Maintains Price Target to $12
Barclays analyst Eliana Merle downgrades Regenxbio (NASDAQ:RGNX) from Overweight to Equal-Weight and maintains the price target from $12 to $12.
08-07 18:36
Clinical Trial Results Show Extended Benefits for REGENXBIO Retinal Treatments
REGENXBIO Inc. (NASDAQ:RGNX) on Saturday shared long-term clinical trial findings for its experimental gene therapy surabgene lomparvovec (sura-vec, ABBV-RGX-314) targeting wet age-related macular degeneration (wet AMD) and diabetic retinopathy (DR). Long-Term Efficacy In Wet AMD Treatment Data pres...
07-20 22:45
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq 100 futures falling around 2% on Friday. Shares of Intuitive Surgical Inc (NASDAQ:ISRG) fell sharply in pre-market trading after the company reported second-quarter financial results. Intuitive Surgical reported quarterly earnings of $2.80 ...
07-17 20:02
REGENXBIO announces $100M common stock offering
REGENXBIO (RGNX) announced on Thursday that it intends to offer and sell $100 million of its common stock in an underwritten public offering. Shares of RGNX dipped 1.70% during post-market trading ho...
07-17 04:33
REGENXBIO Plans To Commence $100M Common Stock Offering
REGENXBIO Inc. (NASDAQ:RGNX) today announced that it intends to offer and sell, subject to market conditions, $100 million of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering ...
07-17 04:27
